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Abstract
Background: Ischemic heart disease (IHD) affects at least 150,000 veterans annually in the United States.
Lowering serum cholesterol has been shown to reduce coronary events, cardiac death, and total mortality among
high risk patients. Electronic clinical reminders available at the point of care delivery have been developed to
improve lipid measurement and management in the Veterans Health Administration (VHA). Our objective was to
report on a hospital-level intervention to implement and encourage use of the electronic clinical reminders.
Methods: The implementation used a quasi-experimental design with a comparison group of hospitals. In the
intervention hospitals (N = 3), we used a multi-faceted intervention to encourage use of the electronic clinical
reminders. We evaluated the degree of reminder use and how patient-level outcomes varied at the intervention
and comparison sites (N = 3), with and without adjusting for self-reported reminder use.
Results: The national electronic clinical reminders were implemented in all of the intervention sites during the
intervention period. A total of 5,438 patients with prior diagnosis of ischemic heart disease received care in the
six hospitals (3 intervention and 3 comparison) throughout the 12-month intervention. The process evaluation
showed variation in use of reminders at each site. Without controlling for provider self-report of use of the
reminders, there appeared to be a significant improvement in lipid measurement in the intervention sites (OR
1.96, 95% CI 1.34, 2.88). Controlling for use of reminders, the amount of improvement in lipid measurement in
the intervention sites was even greater (OR 2.35, CI 1.96, 2.81). Adjusting for reminder use demonstrated that
only one of the intervention hospitals had a significant effect of the intervention. There was no significant change
in management of hyperlipidemia associated with the intervention.
Conclusion: There may be some benefit to focused effort to implement electronic clinical reminders, although
reminders designed to improve relatively simple tasks, such as ordering tests, may be more beneficial than
reminders designed to improve more complex tasks, such as initiating or titrating medications, because of the less
complex nature of the task. There is value in monitoring the process, as well as outcome, of an implementation
effort.
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Background
Ischemic heart disease (IHD) is one of the leading causes
of death in the United States' veteran population. It affects
at least 150,000 veterans annually and is the primary diag-
nosis in approximately one out of 17 admissions to Veter-
ans Health Administration (VHA) hospitals [1,2]
Numerous studies have demonstrated that lowering
serum cholesterol levels, specifically low-density lipopro-
tein cholesterol (LDC-c), reduces coronary events, cardiac
death, and total mortality, with benefits accruing particu-
larly to patients with pre-existing heart disease [3-7] In
1997, the VHA adopted comprehensive guidelines which
followed recommendations of national organizations for
treating patients with IHD and called for lowering LDL-c
to 100 mg/dL or less in patients with known IHD [8-10].
However, research has indicated that veterans receiving
primary care in VHA may not have had their LDL-c meas-
ured or received treatment with lipid-lowering agents at
optimal rates [11,12].
Clinical practice guidelines are known to be difficult to
implement. Many studies have tested interventions to
improve adherence to clinical practice guidelines for a
variety of conditions and in a range of settings, but even
after intervention, these studies find wide variation in
guideline adherence and fail to find any specific interven-
tions consistently associated with improved adherence
[13-18]. Several meta-analyses have suggested the need
for a systems approach combining multiple interventions
and addressing contextual factors [15,19-23] – although
even here doubts have emerged [24]. Among individual
interventions, electronic reminders have been found to be
modestly effective in increasing adherence to certain types
of guidelines, including screening guidelines [25], and
reminders may be more effective, on average, than other
interventions [15,16].
Prior studies have found that reminders are not consist-
ently used by clinicians when they are made available [26-
30]. Few have provided details of efforts made to imple-
ment and assist clinicians in learning how to use remind-
ers that are available.
In this article, we report results of an exploratory study of
a multi-site, multi-faceted quality improvement interven-
tion tailored to local contexts and designed to implement
electronic clinical reminders in order to improve rates of
LDL-c measurement and pharmacologic management
among VA IHD patients. The study was initially planned
as a first step in designing a randomized controlled trial to
implement a complex intervention [31], and was explora-
tory in nature. Our original intent had been to follow this
preliminary study with a larger, multi-site study in which
we had planned to test the effectiveness of a complex,
multi-level, multi-faceted intervention. In the planned
intervention, we would have tested, in part, the effective-
ness of implementing clinical reminders with and without
the type of facilitation we describe in this paper. For sev-
eral reasons, this larger study did not proceed.
This article is one in a Series of articles documenting
implementation science frameworks and approaches
developed by the U.S. Department of Veterans Affairs
Quality Enhancement Research Initiative (QUERI).
QUERI is briefly outlined in Table 1 and is described in
more detail in previous publications [32,33]. The Series'
Table 1: The VA Quality Enhancement Research Initiative (QUERI)
The U.S. Department of Veterans Affairs' (VA) Quality Enhancement Research Initiative (QUERI) was launched in 1998. QUERI was designed to 
harness VA's health services research expertise and resources in an ongoing system-wide effort to improve the performance of the VA healthcare 
system and, thus, quality of care for veterans.
QUERI researchers collaborate with VA policy and practice leaders, clinicians, and operations staff to implement appropriate evidence-based 
practices into routine clinical care. They work within distinct disease- or condition-specific QUERI Centers and utilize a standard six-step process:
1) Identify high-risk/high-volume diseases or problems.
2) Identify best practices.
3) Define existing practice patterns and outcomes across the VA and current variation from best practices.
4) Identify and implement interventions to promote best practices.
5) Document that best practices improve outcomes.
6) Document that outcomes are associated with improved health-related quality of life.
Within Step 4, QUERI implementation efforts generally follow a sequence of four phases to enable the refinement and spread of effective and 
sustainable implementation programs across multiple VA medical centers and clinics. The phases include:
1) Single-site pilot,
2) Small-scale, multi-site implementation trial,
3) Large-scale, multi-region implementation trial, and
4) System-wide rollout.
Researchers employ additional QUERI frameworks and tools, as highlighted in this Series, to enhance achievement of each project's quality 
improvement and implementation science goals.Implementation Science 2008, 3:28 http://www.implementationscience.com/content/3/1/28
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introductory article [34] highlights aspects of QUERI that
are related specifically to implementation science, and
describes additional types of articles contained in the
Series.
Methods
Study design
We conducted a quasi-experimental study using a hospital
level intervention to implement electronic clinical
reminders with the goal of improving hyperlipidemia
management in VA IHD patients. Intervention hospitals
included three VHA hospitals and their satellite clinics on
the eastern side of the Rocky Mountain Network (Sites A,
B, and C), one of 21 regional networks within VHA. Com-
parison hospitals, in which no efforts were made to imple-
ment or encourage the use of the national clinical
reminders, were the three VHA hospitals on the western
side of the Rocky Mountain Network (Sites D, E, and F).
In both the intervention and comparison groups, one of
the three hospitals is a large, urban, tertiary hospital (Sites
B and F), while the other two are smaller, non-tertiary
hospitals in relatively small towns (Sites A, C, D, and E).
In the three intervention hospitals, the two smaller hospi-
tals (A and C) each had two to three satellite clinics, while
the large hospital had eight satellite clinics.
We did not randomize sites to either intervention or com-
parison arms because of geographic differences between
the two halves of the regional network, feasibility due to
travel and budget restrictions, and because of concerns
about the integrity of referral networks in each half of the
regional network. This latter concern was expressed by the
regional leaders who gave approval to conduct the inter-
vention. Regional leaders advised working within the
existing structure of the network as we conducted the
intervention. Our original intent was to use a lagged
design, introducing the intervention to the comparison
half of the region following completion of the interven-
tion in the first half. Because of delays in developing and
releasing the reminders, we were not able to complete
implementation in the comparison sites before the con-
clusion of the study period.
Primary care providers, consisting of general internists,
family practitioners, nurse practitioners, nurses, and/or
physician assistants, were the targets of the intervention.
However, as we note below in our description of the
reminders, the reminders could be viewed by other pro-
viders, such as health technicians or pharmacists, within
the care team. We did not include these other providers in
our training or facilitation efforts.
The intervention
The intervention consisted of an internally and externally
facilitated implementation of national electronic lipid
clinical reminders to promote guideline-recommended
secondary prevention for IHD and began with a kickoff
meeting attended by interdisciplinary teams of three to
eight primary care providers from each of the intervention
hospitals (Table 2). To ensure identification and partici-
pation of local opinion leaders in the kickoff meetings,
team members were selected through an iterative process
of surveys, contacts with hospital and regional leadership,
and expressions of interest on the part of clinicians.
The kickoff meeting included talks by local and national
experts in cardiology and lipid management. Teams from
each hospital participated in small group sessions review-
ing known barriers and facilitators to implementing new
practices within their hospitals, and discussed specific bar-
riers and concerns about their hospitals. Participants com-
pleted surveys designed to measure their perceptions of
organizational readiness to change, and discussed the
aggregate findings in the context of preparing system
change. They were trained in the installation and use of
reminders and were provided with the necessary support
to enable them to champion the implementation of the
national electronic clinical reminders in their facilities.
Following the kickoff meeting, bi-monthly conference
calls with intermittent one-on-one phone and email con-
tact were held between all participating intervention team
members and the lead intervention teams based in Seattle
and Denver. The Seattle team consisted of the principal
investigator, a project director who had overall responsi-
bility for project management and coordination, and a
programmer/analyst. The Denver team consisted of the
co-PI, a project manager who had primary responsibility
for contact with the intervention sites, and a programmer/
analyst. Through such contact, teams were able to give
reports and discuss barriers encountered. Teams that had
overcome some of the identified barriers offered solutions
to others. The intervention period was from June 2002
(when the kickoff meeting was held) through September
2003.
The reminders
The two VHA national lipid clinical reminders were
released in May 2002 as an addition to the VHA Compu-
terized Patient Record System (CPRS). CPRS is a fully elec-
tronic medical record system with computerized order
entry, including laboratory tests, medication ordering,
and consultation [35]. The first reminder is triggered by
the absence of an LDL-c value within the past 15 months
for patients with documented IHD in their medical
record, either in the problem list or as an ICD-9 code in
the discharge codes for each visit or admission. It consists
of a dialog box that reminds the provider that LDL-c test-
ing is due and briefly describes the evidence for taking
action. Check boxes within the dialog box permit the pro-I
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Table 2: Intervention and comparison facility descriptions
Intervention Comparison
Site A Site B Site C Site D Site E Site F
Site description Small non-tertiary facility in a 
relatively small city; frontier 
state
Large tertiary teaching center in 
a large metropolitan area with 
several smaller clinics in outlying 
areas
Very small non-tertiary facility in 
a small city in extremely remote 
area
Relatively large non-tertiary 
outpatient only facility with 
several smaller clinics in outlying 
areas
Small non-tertiary facility in a 
relatively small city; frontier area
Large tertiary teaching center in 
a large metropolitan area with 
several smaller clinics in outlying 
areas
Number of patients with IHD 
during entire study period
1883 4440 1001 4021 1399 5763
Number of primary care 
providers
14 60 9 22 11 83
Proportion of PCPs who 
responded to survey
80% 78% 96% 80% 70% 57%
Proportion of PCPs who are 
MDs
65% 53% 79% 62% 71% 33%
Proportion of PCPs who are 
over 45 years old
60% 58% 50% 46% 43% 36%
Proportion male PCPs 57% 46% 81% 28% 73% 43%
Proportion PCPs stating they 
feel clinical reminders are 
useful
45% 49% 50% 71% 64% 39%
Commitment to intervention at baseline
Size of team attending kick off 
meeting
3 of 8 8 of 21 4 of 9 NA
Composition of team 
attending kick off meeting
1 MD, 2 RNs 1 QM, 1 Admin, 6 NPs or PAs 2 MDs, 2 RNs
PCP-Primary Care ProviderImplementation Science 2008, 3:28 http://www.implementationscience.com/content/3/1/28
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vider to directly order the required lab test. VHA CPRS
electronic clinical reminders do not "pop up" for clinician
viewing. Instead, once triggered, they appear in a folder
that is available through the face page of the patient's
record when it is first opened by the clinician. A reminders
tab is available whenever the patient record is open. We
conducted the intervention in part because of the passive
nature of VHA clinical reminders, believing that addi-
tional championship and training would be required to
encourage providers to use the reminders.
This reminder can be completed by primary care providers
or ancillary clinical personnel, including nurses. The sec-
ond reminder is triggered by a current LDL-c of 130 mg/
dL or greater. It consists of a dialog box with options for
treatment including check boxes for direct ordering of
medications (e.g., statins). In both cases, providers have
the option of checking a box indicating that the diagnosis
of IHD is inaccurate, or that they have chosen not to take
recommended action based on clinical judgment.
The reminders were developed and released nationally by
the VHA and were available to every VHA facility [26,35].
However, their use was not mandated by VHA Central
Office. Decisions were made locally regarding whether to
activate reminders for a hospital, clinic, or individual pro-
vider. Previous research has documented extensive varia-
tion across the VA as to whether or not reminders are
activated [26]. While both the intervention and control
hospitals had access to the national reminders, the inter-
vention to implement the reminders occurred only in the
intervention hospitals. The reminders were installed in
the intervention hospitals within a month after the kickoff
meeting, although there was considerable variation
among the intervention sites in when the reminders were
activated. In two of the comparison hospitals, the
national reminders were activated at some point during
the intervention period, even though no specific imple-
mentation efforts were undertaken. We do not have infor-
mation about when the reminders were activated in these
two comparison facilities.
Patient population
Patients with a diagnosis of IHD who received care at the
intervention or comparison hospitals during the observa-
tion period of September 2002 through June 2003 (i.e.,
they had at least one primary care visit during this period)
were eligible for this study. Patients were identified as hav-
ing IHD if they had an ICD-9-CM code of 410.xx (acute
myocardial infarction), 411.xx (other acute and subacute
forms of ischemic heart disease), 412.xx (old myocardial
infarction), or 414.xx (other forms of ischemic heart dis-
ease) in the VA National Patient Care Databases (NPCD),
and if they had been seen in primary care in a VHA hospi-
tal at least twice in the past three years. The algorithm for
patient identification has been previously described by
Sloan and colleagues [12].
Patient-level data, including age, gender, race/ethnicity,
co-morbid conditions, self-reported income, lab values,
and medication prescriptions were obtained from three
sources. One was the VA regional Decision Support Sys-
tem (DSS), which contains laboratory and other clinical
information for all patient encounters. The second data
source was the VA Pharmacy Benefits Management (PBM)
database, which contains detailed medication data on all
VHA patients. The third was the NPCD, which contains
records of all inpatient admissions and outpatient
encounters. The same patient-level data were available for
patients in both intervention and comparison hospitals.
Patient age at baseline, gender, race/ethnicity, self-
reported income, and number of co-morbid conditions
were used to adjust the patient level outcomes. Race/eth-
nicity was coded as white/non-white, where patients for
whom race/ethnicity was missing in administrative data
(27%) were coded non-white. We repeated the analysis
coding these patients as white, or missing, and found that
it did not affect the results. The following diseases were
coded as co-morbidities, and each scored one in the count
of co-morbid conditions: diabetes, renal disease, chronic
heart failure, depression, stroke, peripheral vascular dis-
ease, and substance use disorder. These conditions have
been related to lipid measurement and treatment in our
prior studies. Human subjects review and approval was
obtained from the relevant institutional review boards.
Study measures
We tracked participation in the intervention by the teams
in each intervention hospital through conference calls,
email messages, and other contacts with the intervention
teams during the course of the intervention period. We
compiled the data from the tracking system to report on
barriers experienced by the intervention teams during the
course of the intervention, and report these as specific
events experienced in each hospital in a barriers section at
the beginning of the results section.
We collected clinic-level data from each hospital detailing
the number of clinical reminders due for patients, as well
as the number of reminders satisfied (i.e., an action was
taken which met the predetermined criteria for satisfying
the reminder) on a weekly basis for the last half of the
intervention period (May to September 2003). Reminder
counts were tabulated only for the last half of the inter-
vention period because data were only available for this
period.
These data were available only in the intervention hospi-
tals (Figures 1 and 2). In addition, we conducted a survey
in June 2003, administered by email, of providers in bothImplementation Science 2008, 3:28 http://www.implementationscience.com/content/3/1/28
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intervention and comparison hospitals, asking them
about their use of and perceptions about electronic clini-
cal reminders generally, and the IHD national clinical
reminders in particular [Additional file 1]. Our informa-
tion about use of reminders in the comparison hospitals
and clinics comes from this survey.
The patient-level outcomes measured in this study
included the changes in the proportion of IHD patients
with current LDL-c measurement, and the proportion of
patients with elevated LDL-c receiving lipid-lowering ther-
apy to show the effect of the intervention on key process
measures between June 2002 and September 2003 in both
the intervention and comparison hospitals. In the first
analysis, we did not control for the degree of reminder
use, measured by the proportion of providers who report
using IHD reminders frequently at each site (both inter-
vention and comparison). In the second analysis, we con-
trolled for the degree of reminder use.
Analysis
For the process evaluation of the intervention, we assessed
the degree to which hospitals varied in their patient and
provider characteristics at baseline. We conducted a qual-
itative assessment of intervention team participants' views
on their organizations readiness to adopt practice change.
We monitored and graphed trends in lipid measurement
and lipid levels among patients with IHD at the interven-
tion sites throughout the majority of the intervention
period. We reported frequency of reminder use at the
intervention sites from the reports that are generated from
the electronic reminders (reminder reports). We also
assessed provider self-report data on their use of electronic
clinical reminders, both the two IHD reminders and other
locally developed reminders.
For the summative or outcome evaluation, we conducted
bivariate analyses comparing the change in proportion of
patients with current LDL-c measurement and the propor-
tion of patients with elevated LDL-c who were receiving
lipid-lowering medication between intervention and
comparison hospitals and between the beginning and end
of the intervention period, using analysis of variance and
the F-statistic or tabulation with χ2 for inference testing.
We included only those IHD patients who were present in
all time periods during the study period. We also con-
ducted multivariable analysis using two multivariable
logistic regression models: the first for positive change in
current measurement of LDL-c (i.e., patients without cur-
rent measurement at baseline who had current measure-
ment at the end of the intervention), and the second for
positive change in prescribing lipid lowering agents for
patients with LDL-c greater than 130 mg/dL. We entered a
variable indicating intervention site in the multivariable
analysis, and we used a cluster correction to correct for
clustering by hospital. Finally, we adjusted for provider
self-report of reminder use, as this measured whether or
not the reminder actually was used, rather than assuming
use based on the allocation by hospital to intervention or
not. All analyses were conducted using Stata version 9.0.
Multivariable analyses were conducted using logistic
regression with a binary dependent variable indicating
improvement in measurement or lipid level, adjusted for
clustering using Stata's "cluster" command. This com-
mand corrects the standard errors for the effect of autocor-
relation due to hospital.
Results
As shown in Table 2, there was significant variation
between individual hospitals in the number of patients
diagnosed with IHD, number of primary care providers,
and other characteristics. This variability occurred across
Percentage of patients at each of the three intervention sites  with diagnosed IHD who had LDL-c measurement reminders  due from May to September 2003 Figure 1
Percentage of patients at each of the three intervention sites 
with diagnosed IHD who had LDL-c measurement reminders 
due from May to September 2003.
Percentage of patients at each of the three intervention sites  who had a diagnosis of IHD and an elevated LDL-c measure- ment for whom treatment reminders were due from May to  September 2003 Figure 2
Percentage of patients at each of the three intervention sites 
who had a diagnosis of IHD and an elevated LDL-c measure-
ment for whom treatment reminders were due from May to 
September 2003.Implementation Science 2008, 3:28 http://www.implementationscience.com/content/3/1/28
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both the intervention and comparison hospital groups.
The number of patients included in the analysis was 5438,
with a slightly higher proportion in the comparison hos-
pitals (Table 3). More patients were identified as having
IHD over the study period, as shown in Table 2. However,
only 5438 patients were present at the beginning and end
of the study, forming the cohort we followed over time.
The intervention hospitals had slightly younger, lower
income, and lower proportion white and male patient
populations than the comparison hospitals. They also dif-
fered in the proportion of patients with LDL-c measured
at baseline, with the intervention hospitals having a
slightly lower rate of measurement. There was no differ-
ence between the two groups in the proportion of patients
with elevated LDL-c receiving lipid-lowering medications
at baseline.
Barriers to implementing the reminders
Barriers included: Use of a diagnosis code that was differ-
ent from those used within the reminder logic to identify
IHD patients (Site C only); inability to find reminder
experts who could train clinicians in their use (Site A
only); lack of IT support staff to install and turn on the
reminders (primarily affecting Sites A and B); and an
organizational merger that took priority over all other
activities (Site B only). Of note, none of the sites indicated
that time for clinicians to use the reminder was a signifi-
cant barrier, although time burdens are consistently cited
among the most frequent barriers to clinical reminders.
The passive nature of the reminders may have been a fac-
tor in limiting the degree to which reminders presented a
burden for providers.
Barrier resolution included changing coding practice at
Site C (unknown amount of time to resolve); and sched-
uling a training session at Site A, with the reminder cham-
pion from Site C traveling to participate in the training to
make it relevant for clinicians (three months to resolve).
The two barriers encountered at Site B were not readily
resolvable, although the local team and our implementa-
tion team worked diligently to ameliorate the situation.
Overall, the local team member morale remained high
and the teams remained engaged throughout the interven-
tion period.
Reminder use from reminder reports
The trend lines for measurement reminders due for each
of the three intervention hospitals over the five-month
period for which reminder reports were available is shown
in Figure 1; the trends were mixed in the three hospitals.
Lower levels of measurement and treatment reminders
due are indicative of increased guideline compliance, thus
the desired trend would be a downward slope. Site A dis-
played a trend towards a decrease in the proportion of
IHD patients with measurement reminders due, while Site
B increased slightly initially, then decreased, and Site C
decreased initially and then increased. The trends for
treatment reminders due were different and are shown in
Figure 2; Site A started low and stayed relatively flat, while
Site B initially decreased, then increased slightly, and
finally decreased considerably, and Site C initially
increased, stayed relatively flat, and decreased at the end
of the intervention period. We present summary statistics
from the reminder reports in Table 4.
Reminder use from provider self-report (survey data)
The provider survey data from both the intervention and
comparison hospitals showed considerable variation
across the sites (Table 5). On average, comparison sites
reported higher overall use of electronic reminders
(98.2% versus 88.4%, p = 0.03), and their use was uni-
formly high (over 90% in all sites). Intervention hospitals
reported higher use, on average, of general lipid reminders
than comparison hospitals (38.8% versus 20.3%, p =
0.01), however, there was considerable variation within
intervention and comparison groups.
There was also variation in attitudes expressed by provid-
ers, in the degree to which providers reported that the IHD
reminders were useful, with intervention hospitals gener-
ally reporting that they were more useful (32.3% versus
16.2%, p = 0.02); that they increased awareness of the
need for measurement and treatment of these patients
(30.3% versus 14.9%, p = 0.02); and, to a lesser degree,
Table 3: Patient characteristics in both intervention and comparison VHA hospitals at baseline
Patient characteristics Intervention Comparison p-value
N = 2372 N = 3066
Mean age 69.0 (s.d. 10.3) 70.7 (s.d. 9.6) <0.001
% male 98.2 98.6 0.02
% white 66% 68% 0.02
% income less than $20,000 per year 62% 55% <0.001
Mean number of comorbidities 0.99 (s.d. 1.01) 0.98 (s.d.0.98) 0.68
% with current LDL-c at baseline 91.2% 94.0% <0.001
% on lipid lowering agents at baseline among IHD patients with LDL-c > 130 mg/dL 79.6% 80.2% 0.884Implementation Science 2008, 3:28 http://www.implementationscience.com/content/3/1/28
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recommended appropriate treatment or action options
(28.7% versus 15.8%, p = 0.06). There was less than max-
imal contrast in reminder use between intervention and
control hospitals.
Summative outcomes: Change in measuring and managing 
lipids
As shown in Table 6, the results of the summative evalua-
tion showed that the intervention hospitals performed
better overall in improving LDL-c measurement than did
the comparison hospitals, adjusting for patient character-
istics (odds ratio 1.96, 95% CI 1.43–2.88). However,
there was no significant difference between the interven-
tion and comparison hospitals in their treatment of
patients requiring lipid-lowering medications. The effect
of the intervention on lipid measurement was stronger for
LDL-c measurement when the amount of reminder use, as
reported by providers, was included in the adjustment
(OR 2.35, 95% CI 1.96–2.81). Notably, the odds ratios
for the two smaller intervention hospitals became insig-
nificant after adjusting for self-reported reminder use,
while the odds ratio for the large intervention site
remained significant (OR 1.77, 95% CI 1.11–2.82).
The odds of treatment for patients requiring medications
was somewhat lower for intervention sites after adjusting
for reminder use, but remained statistically indistinguish-
able from comparison sites.
Discussion
The primary aim of this study was to explore the imple-
mentation of electronic clinical reminders in order to
improve rates of LDL-c measurement and pharmacologic
management among patients with known ischemic heart
disease in VHA. There is no literature to date on the use of
a hospital-level intervention to improve the use of elec-
tronic clinical reminders. However, consistent with prior
papers reporting the results of process evaluation of a
reminder intervention [29], we found that there appears
to be an association between how much providers report
Table 4: Process outcomes: Reminder reports (Intervention hospitals only)
Site A Site B Site C
Number of IHD patients identified by electronic lipid reminders at each site 720 1404 475
Proportion of IHD patients with electronic lipid reminders due for LDL measurement at beginning of 
study period
27% 19% 21%
Proportion of IHD patients with electronic lipid reminders due for LDL measurement at end of study 
period
20% 15% 23%
Proportion of patients with electronic lipid reminders due for lipid lowering treatment at beginning of 
study period
10% 14% 11%
Proportion of patients with electronic lipid reminders due for lipid lowering treatment at end of study 
period
11% 8% 13%
Table 5: Process outcomes: Provider survey responses
Site Site
Intervention 
hospitals 
overall
Comparison 
hospitals 
overall
p-value A B C p-value D E F p-value
Proportion of primary care clinicians 
who report using any electronic 
reminders whether the national IHD 
reminders or not *(from provider 
survey)
88.4% 98.2% 0.04 64.3% 94.9% 93.7% 0.01 100% 100% 96.4% 0.59
Proportion reporting frequent use of 
IHD electronic reminders
38.4% 20.3% 0.01 30.0% 36.4% 50.0% 0.38 45.8% 21.4% 2.8% <0.001
Proportion reporting that IHD 
electronic reminders are very useful
32.3% 16.2% 0.02 35.0% 29.1% 37.5% 0.77 37.5% 14.3% 2.8% 0.001
Proportion reporting that IHD 
electronic reminders increase 
awareness of lipid monitoring for IHD 
patients
30.3% 14.9% 0.02 30.0% 25.4% 41.7% 0.35 29.2% 21.4% 2.8% 0.008
Proportion reporting that electronic 
reminder screens provide appropriate 
treatment/action options
27.3% 14.9% 0.06 25.0% 23.6% 37.5% 0.48 37.5% 7.1% 2.8%
*Comparison sites had access to electronic IHD reminders, but were not encouraged to turn them on, nor was the implementation intervention 
deployed at these sites.Implementation Science 2008, 3:28 http://www.implementationscience.com/content/3/1/28
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using reminders with change in the patient-level outcome
measures only for the measurement reminder.
Providers at all six sites (intervention and control)
reported using reminders, although not necessarily the
two specific reminders that were the subject of this imple-
mentation effort. We note that use of reminders is self-
reported, and may not fully reflect actual use; in particu-
lar, providers may over-report use of reminders when
asked to self-report. At the intervention hospitals, the
measurement reminder (prompting the clinician to order
a test measuring LDL-c when no current measurement was
available in the record) appears to have been effective in
increasing the proportion of patients with current LDL-c
measurements. However, the treatment reminder
(prompting clinicians to begin a medication when a
patient was not on a lipid-lowering medication and had
elevated LDL-c) appears not to have been effective, even
when we took into account self-reported use of the
reminder [19,20,22].
Data from the reminder reports suggested that the
reminder due rates were not very high in the intervention
hospitals, ranging from 19 to 27% for measurement and
10 to 14% for treatment (Table 4). Despite these low rates
overall, there was more room for improvement in the
measurement outcome than in the treatment outcome,
and the lower response to the intervention for the treat-
ment outcome may be related to the relatively low rate of
reminders due at the beginning of the period when
reminder reports became available. It is important to note
that we did not have reminder reports until the latter part
of the intervention period, and it is possible that the effect
of reminders may have been greater earlier in the interven-
tion period.
It is also important to note that VHA clinical reminders
are passive – they do not "pop up" on the screen, but are
housed in a reminders folder in the electronic health
record. This requires that clinicians make an active effort
to view the reminders folder in order to respond to clinical
reminders. In our view, this increases the need for inter-
ventions to make clinicians aware of the reminders and
learn how to use them, and may make it more important
that clinicians have a favorable attitude towards remind-
ers.
There were considerable differences among the sites in
their use of other electronic clinical reminders prior to our
initiating the intervention described in this paper. The
comparison sites had existing electronic reminders for lip-
ids and, in general, had higher levels of lipid reminder use
than the intervention hospitals. While we were not able to
determine exactly when electronic reminder use began in
the comparison sites, it is likely that these sites had been
early adopters of electronic reminders, and had been
using them for a period of years prior to the intervention.
Several papers have described problems in the user inter-
face with electronic clinical reminders, including those
used in VA [26-28,30]. Our findings demonstrate that dif-
Table 6: Summative outcomes: The proportion of patients with current LDL-c measurements and patients prescribed lipid lowering 
medications from baseline to the end of intervention period
Intervention 
versus 
Comparison
Individual Intervention Sites Individual Comparison Sites
Intervention Site A Site B Site C Site D Site E Site F
Odds ratio for change from baseline to end of intervention without adjusting for degree of implementation (95% confidence intervals)*
Effect on proportion of patients with 
current LDL-c from baseline to end 
of intervention period¶
1.96 (1.34,2.88) 1.45 
(1.38,1.52)
1.57 
(1.44,1.72)
1.64 
(1.53,1.75)
0.57 
(0.50,0.66)
0.67 
(0.65,0.68)
Reference
Effect on proportion of patients on 
lipid-lowering medications from 
baseline to intervention period¶
0.92 (0.72,1.19) 0.89 
(0.87,0.91)
1.10 
(1.01,1.20)
0.54 
(0.53,0.56)
1.30 
(1.07,1.57)
0.68 
(0.66,0.71)
Reference
Odds ratio for change from baseline to end of intervention adjusting for provider self-reported amount of use of IHD reminder (95% CI)
Effect on proportion of patients with 
current LDL-c from baseline to end 
of intervention period
2.35 (1.96,2.81) 1.33 (0.93,1.89) 1.77 
(1.11,2.82)
1.46 (0.77,2.76) 0.34 
(0.27,0.43)
0.58 
(0.45,0.75)
Reference
Effect on proportion of patients on 
lipid-lowering medications from 
baseline to intervention period
0.87 (0.67,1.13) 0.85 (0.71,1.03) 1.05 (0.82,1.35) 0.46 
(0.34,0.61)
1.35 (0.97,1.90) 0.66 
(0.59,0.75)
Reference
*Adjusted for patient baseline and facility characteristics in Table 2; odds ratios significant at p < 0.05 bolded
§Intra-class correlation for measurement change was 0.08, 95% CI 0.00 – 0.18
¶Intra-class correlation for treatment change was 0.02, 95% CI 0.00 – 0.05Implementation Science 2008, 3:28 http://www.implementationscience.com/content/3/1/28
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ficulties may persist even when specific facilitation
attempts are made, through training and support, to
improve reminder use. It is notable that attitudes towards
reminders reported by providers were more positive over-
all in the intervention than the comparison hospitals,
despite the lower reported use of reminders.
This study also highlights the importance of including a
comparison group when conducting studies designed to
evaluate quality improvement interventions. If this study
had consisted only of a pre-and post-intervention assess-
ment of the change in proportion of measurement and
treatment reminders due we may erroneously attributed
significant changes in performance measures to the
reminders. Having comparison sites allowed us to
acknowledge that prior use of reminders was a critical fac-
tor in whether reminders were adopted or not, and
whether they were used or not.
Prior to this study, we had completed work in several VA
sites that revealed substantial performance gaps in meas-
uring LDL-c and in treating high LDL-c levels (greater than
130 mg/dL) among veterans with IHD [12,36,37]. How-
ever, there were considerable delays in the development
and testing of the national reminders. By the time we
engaged in this implementation effort, trends had been
improving in lipid measurement and management for
IHD patients system-wide. It may have been advanta-
geous, therefore, to have reassessed the level of perform-
ance gaps within these institutions prior to implementing
the intervention. Alternatively, once developed, quality
improvement interventions need to be rapidly imple-
mented so that temporal changes in performance do not
occur between baseline measurement and intervention
implementation.
There is considerable literature on the effectiveness of
reminders, much of which is undermined by not adjust-
ing for either organizational or hierarchical variables, or
for the degree of reminder use [29,38,39]. In this study,
we controlled for the clustering inherent in an organiza-
tion-level intervention and, as much as possible, for the
degree to which the use of reminders may have affected
outcomes. Our findings are consistent with a number of
studies that have reported on the effectiveness of remind-
ers[18-20,22,24].
Finally, our findings underscore the importance of forma-
tive and process evaluation in implementation research:
first to maintain fidelity to the original intention of the
intervention, and second to understand the degree of
uptake of the implementation [29]. Our process evalua-
tion included tracking conference calls and email mes-
sages, including content of discussion of implementation
barriers and their resolution; a survey of providers asking
about their use of reminders; and use of an informatics
tool, the reports generated by reminders.
Strengths and limitations
The quasi-experimental design was an important strength
of this study which allowed us to evaluate the effects of the
reminders in the intervention sites adjusting for temporal
trends. However, because allocation to the intervention
group was non-random, there is a threat from unobserved
confounders. Comparison sites were also non-optimal
because they had existing electronic reminders for lipids,
and temporal trends in lipid performance measures may
have been different for facilities with electronic reminders
versus those without. An ideal control group would have
been a matched set of sites without a reminder system. In
addition, we were able to obtain reminders due and satis-
fied (process measure) data only for part of the interven-
tion period. However, a strength of this study is having
these data at all. Also it should be noted that the response
rates at each site were variable (Table 2), a factor we were
not able to control. In addition, we lacked reminder
report data early on in the intervention period, when there
may have been greater use of the reminders. Finally, this
study was conducted in a single healthcare system, VHA,
which is known for its advanced informatics capacity, and
may not be easily generalized to other settings.
Conclusion
Although the data suggest that the implementation effort
may have had some impact, the effect of the implementa-
tion effort reported in this study is modest. This finding is
consistent with reports of implementation efforts focused
at the organizational level. Our study generated some new
insights into how clinicians respond to reminders that
focus on different aspects of a clinical problem, namely
detection or screening versus medication initiation or
intensification. This study also demonstrates the impor-
tance of including contemporary controls when evaluat-
ing quality improvement interventions. We also report
some substantial barriers to implementing reminders at a
facility level, including a possible significant effect of prior
culture and attitudes towards reminders. Our findings
suggest that assessing these factors is likely to be an essen-
tial component to successful implementation of elec-
tronic clinical reminders, and finding methods of
intervening if negative attitudes or an unsupportive cul-
ture are present. It may be very important to have enough
resources to respond to these barriers as part of an imple-
mentation plan.
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